7 0.10623 virus viral viruses infection host replication influenza human cell hiv infected cells rna antiviral infections studies genome infectious strains denv entry humans disease cellular particles zikv important type including hsv immune proteins hcv hepatitis resistance highly strain development infect high transmission spread target potential receptor ebov specific culture early mutations capsid genetic recent shown dengue dna mechanisms recently avian animal infectivity ability family envelope treatment virions vitro factors respiratory effective receptors chikv major number agents effects similar natural mutation acid polymerase due found system ebola pathogenic demonstrated severe types effect replicate susceptible virulence hev required result lines fever primary mechanism
27 0.09595 study group data studies results analysis significant groups age compared higher included table significantly risk patients participants total reported years test time number found factors differences control variables score effect period performed difference level subjects levels showed population day treatment rate conducted sample previous positive median high based days hospital findings collected observed methods statistical lower association increased analyses intervention regression prevalence scores model low baseline outcome mortality information outcomes assessed medical values health effects statistically clinical status measured criteria received range correlation year care months research survey characteristics average cohort university review ratio symptoms rates increase conclusion identified assess
6 0.09125 health public research information disease data care diseases system surveillance work systems national medical response countries development management provide global emergency support infectious resources international training including control process potential community important approach knowledge clinical include access time safety services program quality capacity review issues pandemic programs local developed risk based critical medicine prevention laboratory specific practice efforts communication scientific states level key emerging implementation e.g provided activities challenges assessment relevant preparedness human future report effective current ensure improve needed required disaster developing reporting planning identify field healthcare staff technology funding outbreak focus areas strategies biological monitoring plan world articles
5 0.08837 cells fig cell figure min protein incubated expression control data infected performed assay pbs medium infection antibody results analysis buffer previously culture shown observed virus added washed determined treated experiments analyzed compared serum plates samples usa study showed activity detected levels effect total concentration obtained antibodies measured treatment incubation times purified western collected significantly time transfected expressed staining significant viral vero presence temperature diluted supernatant days plasmid vector determine stained cultures fold concentrations room kit human hours prepared test dilution blot previous supernatants mg/ml cultured mouse level supplemented invitrogen fixed fluorescence harvested standard moi solution lines line pcr overnight recombinant
0 0.08022 samples pcr detection assay positive dna sample rna assays results sensitivity test detected amplification rt-pcr reaction negative primers clinical methods diagnostic method performed testing specimens virus viral detect primer tests real-time tested specificity table min nucleic diagnosis specific laboratory probe kit analysis molecular study probes control obtained acid target rapid time standard serum collected extraction viruses high gene sensitive based culture blood elisa reverse products developed system multiplex sequencing number sequence pathogens laboratories reference sequences hybridization low extracted polymerase total amplified identification single presence conventional designed values specimen compared applied copies concentration antigen lamp reactions diagnostics step usa previously result
19 0.07583 patients sars infection cases transmission outbreak care health patient disease hospital contact control risk respiratory case infectious reported workers spread pandemic outbreaks medical healthcare isolation staff infected symptoms measures hospitals days mers-cov illness influenza infections exposure fever epidemic virus public mers travel hand including prevention time period diseases persons number people hygiene quarantine contacts high severe countries hcws suspected individuals precautions ppe confirmed protective onset facilities acute close ebola syndrome effective clinical infl areas screening hong procedures equipment kong community occurred protection potential person prevent early saudi cdc room nurses emergency rate masks settings family personnel personal laboratory treatment members
20 0.07066 model data number time models rate population epidemic network individuals disease fig case results transmission probability parameters values distribution figure set based infected infectious cases individual information method system analysis size dynamics i.e function average parameter approach methods infection networks spatial period contact process estimates table large estimate shown rates effect outbreak state susceptible observed estimated section control e.g shows simulation structure total study small point spread order nodes initial patterns obtained defined algorithm proposed threshold random prediction distance important level modeling equation assumed change due degree show result similar effects expected performance simulations high considered density terms relative calculated
22 0.06327 respiratory influenza children infection rsv virus viruses viral infections study patients age years cases clinical studies symptoms disease detected tract illness infants pneumonia acute adults hrv severe common hmpv human data lower found reported rhinovirus months detection samples pathogens positive days table hbov year specimens identified seasonal adenovirus nasal hospitalized young group compared bacterial including bronchiolitis hospital severity upper piv rates rate pcr fever incidence season parainfluenza population pneumoniae similar significant nasopharyngeal wheezing higher period surveillance number ili risk observed prevalence aged high episodes hospitalization groups hpiv syncytial throat due cough pandemic shown pediatric pathogen asthma illnesses older collected child
23 0.05504 genes sequences gene sequence analysis genome data sequencing genetic table identified species figure human genomes number reads selection fig database based found phylogenetic dna protein set diversity genomic regions proteins study amino nucleotide samples analyses viruses evolutionary evolution host variants tree reference related mutations codon identify methods information single multiple alignment region acid length total selected sites variation performed similar predicted high similarity method supplementary expression group results additional present strains molecular family genotype mutation cluster common compared including studies alleles previously sample significant differences allele functional generated observed large usage snps complete approach library identification groups sequenced shown biological
8 0.05442 health people social china countries public economic risk global government world international tourism policy chinese development market human services years industry change population crisis local urban security political life states million state important hong media national impact major time level food growth kong effects travel demand country research factors areas cities increase business trade year high society including problems risks city price costs disaster management due make measures result sars number made financial united sector production cost general role issues service increased natural income events markets living part future law governments conditions rural policies mental good problem system terms power
11 0.05408 cells immune cell response expression infection responses mice activation production cytokines macrophages tlr role inflammatory cytokine levels human receptor increased type innate studies receptors inflammation lymphocytes shown molecules immunity disease dcs system function lung ifn specific antigen induced important mechanisms epithelial mhc activated expressed signaling found t-cell stimulation induction class monocytes blood vivo induce including cxcl neutrophils lps tissue vitro development effects infections effector ccl host adaptive ifn-γ memory compared ccr surface addition antigens chemokines factor dendritic demonstrated significantly activity peripheral increase high observed model proliferation results mouse reduced diseases control release play mediated complement express enhanced antibodies effect tumor
12 0.05167 sars-cov virus strains mers-cov ibv protein strain coronavirus pedv gene coronaviruses viral sequence viruses orf sequences study tgev cov spike amino sars rna isolates genome group showed respiratory acid analysis china detected infection chickens fig samples nucleotide region reported identified phylogenetic isolated found covs human table type proteins based chicken observed hcov identity rt-pcr infected ace recombination genes including related collected shown birds pdcov similar bat severe genbank isolate previously high fipv positive hku recombinant studies genetic groups rbd nucleocapsid disease performed complete host compared porcine results infectious ndv usa receptor accession highly revealed inoculated dpp animal avian field obtained
25 0.05069 species disease human animals humans transmission diseases bats animal virus bat wild birds host populations zoonotic population pathogens hosts infection areas africa reported rabies risk infectious cases outbreaks poultry found food countries wildlife infected high pathogen domestic including dengue infections spread potential malaria reservoir years avian emergence world asia endemic fever prevalence emerging studies important natural viruses environmental livestock parasite europe transmitted water contact health exposure control parasites america due south mosquitoes caused surveillance range recent e.g mortality regions identified african fish mosquito factors evidence outbreak mammals north vector united individuals detected number region year states increased dogs large rodents
17 0.04957 patients lung respiratory pneumonia asthma pulmonary treatment clinical severe airway acute patient disease therapy symptoms chest icu mortality copd days diagnosis infection ventilation increased failure nasal risk cough ards chronic admission blood exacerbations sputum lower common oxygen studies cap early allergic function care severity hospital alveolar children levels findings exacerbation lungs injury airways high evidence showed day syndrome inflammation normal including mechanical sepsis history cases viral bal management serum rate results study pressure bacterial bronchial fever initial treated inflammatory important corticosteroids group cardiac present response due performed hours antibiotics admitted found factors time imaging upper increase years heart positive significant
3 0.04902 patients blood treatment disease clinical therapy infection hiv risk patient infections cases recipients hepatitis liver plasma transplant cmv diagnosis days acute transplantation hbv years reported chronic donor months cell donors transfusion women cancer severe syndrome hcv children high treated fever due including common antibodies drug incidence increased ebv weeks studies pregnancy testing case time platelet early symptoms dose hsct serum results prophylaxis levels complications mortality renal individuals developed antibody include ribavirin day received pregnant agents survival higher failure screening immune normal bone drugs positive chemotherapy age considered adverse marrow low significant evidence rate primary present phase diseases combination trials performed
13 0.04716 vaccine vaccines antibodies antibody mice immune vaccination responses protein antigen igg response neutralizing recombinant immunization protection epitopes antigens challenge serum immunity dna sera immunized virus epitope mabs proteins specific vaccinated human development titers vector protective group neutralization animals efficacy elisa dose vectors studies induced mab effective high adjuvant animal shown groups induce vlps clinical immunogenicity developed mucosal production inactivated gene live antigenic study iga administration monoclonal attenuated peptide expression levels humoral weeks days produced expressing expressed based control potential peptides influenza mouse administered higher tested strain showed trials doses safety cell injection results titer immunogenic day compared binding demonstrated single
29 0.04312 bacterial bacteria pathogens infections infection resistance strains antimicrobial antibiotic organisms coli isolates antibiotics species aureus culture pathogen agents microbial pneumoniae treatment resistant clinical spp tuberculosis results mrsa organism host disease strain salmonella microorganisms isolated colonization patients toxin methods found cases important cultures susceptibility common caused fungal including virulence studies aeruginosa gram-negative infectious pathogenic tract therapy human growth staphylococcus microbiota factors presence identified fungi oral streptococcus specific agent diseases intestinal microbes toxins present due genes identification include potential difficile type high pneumonia bacterium agar major pseudomonas gut activity recent role mic gram-positive system invasive molecular group candida mycobacterium microbiome drug e.g
1 0.0429 binding protein residues structure domain proteins peptide fig site amino peptides structures structural pro interactions figure acid activity complex interaction residue domains sequence protease shown affinity substrate sites acids region form surface enzyme molecular cleavage crystal active bind conformation similar hydrophobic loop catalytic data receptor fusion bound conserved observed chain molecules found table c-terminal n-terminal position conformational model proteases sars-cov human group ligand specificity fold energy helix side molecule analysis motif studies bond hydrogen core regions pdb based inhibitors determined results chains function identified target pocket sialic predicted docking glycans formation nmr presence high forms recognition sars cysteine mutant complexes
10 0.04006 air water temperature particles concentration fig flow surface exposure environmental time conditions room environment particle high system study size airborne ventilation rate pressure area studies filter surfaces aerosol wind concentrations food shown building contamination higher due process found source results method low heat indoor materials table volume chemical effect efficiency humidity material test inactivation waste sampling lower systems solution removal measured level total droplets gas energy effects quality min temperatures liquid carbon large velocity increase increased light buildings human range number aerosols filtration disinfection methods e.g control transport contaminated cleaning diameter pollution organic risk treatment bacteria relative levels thermal areas
18 0.03749 expression cells ace cell human activity levels cancer effects increased role receptor mice studies protein tissue activation function gene ang liver tumor growth effect increase development found injury rats factor disease system including shown lung treatment stress study tissues significantly involved induced signaling reduced normal rat pathway brain important endothelial expressed inhibition receptors potential plasma oxidative blood enzyme model patients acid diseases mechanisms regulation muscle mouse decreased heart showed inflammation pathways metabolism models kidney vivo addition damage proliferation response demonstrated mechanism results inhibitor inhibitors insulin formation vascular reported factors genes level epithelial glucose mrna fibrosis mmp apoptosis cellular stem control
9 0.03641 rna nsp sequence protein mrna replication genome translation viral proteins synthesis orf dna fig gene site region sequences rnas structure transcription end virus polymerase activity shown mrnas figure codon nucleotides genomic sites mutant nucleotide expression frameshifting vitro rdrp initiation viruses strand mutations mhv template conserved products structures cleavage complex cdna mutants structural utr recombination similar regions presence trna amino domain base found downstream frame transcripts product ribosomal ribosome genes plasmid frameshift required elements helicase function genomes promoter mechanism position subgenomic efficiency secondary coding present pseudoknot predicted replicase yeast results cap kda upstream stem role observed addition length motif mutation reading
28 0.03583 membrane proteins protein cells fusion cell membranes surface lipid entry golgi particles formation vesicles plasma fig transport domain shown cellular assembly found intracellular virions cytoplasmic receptor glycoproteins form complex envelope transmembrane role pathway release localization required process structures viral cholesterol studies budding glycoprotein interaction binding cytoplasm function amino specific signal acid secretory endocytosis involved domains microscopy cleavage similar presence addition virion trafficking observed endosomal processing endosomes acids components region present lipids receptors hcv mechanism electron site channel sites structural complexes particle compartments interactions compartment molecules glycosylation structure small mutant results important nuclear large cathepsin bilayer figure synthesis rab virus nucleus
24 0.03574 calves pigs animals diarrhea infection cattle milk days disease rotavirus piglets prrsv bovine virus infected animal intestinal group calf swine samples age pig fecal porcine study serum clinical herds pcv control farms cows day herd colostrum feed found groups farm diarrhoea period weeks signs high observed production dairy feces pedv reported detected shedding respiratory enteric table bvdv infections mortality small time present intestine fed number sheep treatment experimental neonatal antibodies studies positive feeding higher gastroenteritis sows antibody increased low coli inoculated birth weight cryptosporidium similar strain presence blood prevalence igg large affected significant compared collected oocysts important due elisa water
14 0.03566 cats cells lesions disease dogs infection tissue fig cell cases present feline animals cat occur small common epithelium tissues fip clinical necrosis signs epithelial skin include occurs lymph reported affected mucosa large inflammation chronic found species diagnosis normal canine form liver severe infections result similar infected type surface areas nodes inflammatory blood macrophages develop lymphocytes caused tumors acute commonly fiv characterized virus lesion tract primary nasal examination glands felv including intestine secondary ocular loss diseases edema dog presence mild organs observed occasionally due systemic rabbits rare hyperplasia mucosal intestinal lymphoid neutrophils respiratory frequently vessels infectious death diffuse body age sections
2 0.03274 protein proteins dna target surface delivery sirna cell nanoparticles cells gene high system molecules systems applications approach expression detection developed specific method based potential production methods development drug properties biological process targeting due technology binding human molecular small cancer therapeutic vivo chemical size complex application sirnas techniques mass plants plant low particles fluorescence synthetic applied nps approaches signal large reported acid demonstrated stability solution targets addition modified analysis peptides recently range rnai including studies research peptide technique single design targeted interactions field effective highly efficiency affinity aptamers study nucleic strategy imaging efficient vectors time fluorescent diseases concentration important compared interest
26 0.03142 protein proteins expression cells viral infection ifn signaling activation replication pathway response cell rna cellular activity ifitm autophagy host genes transcription antiviral apoptosis irf gene phosphorylation role pathways type isg dna nuclear induction degradation mrna shown stat binding levels complex figure rig-i kinase immune induced inhibition eif mir interaction innate function involved factor including production stress factors target atg domain regulation virus studies hcv caspase identified cycle important mechanism found dsrna functions inhibit infected results induce mechanisms nf-κb family mda pkr trim mirnas ubiquitin promoter death study human ifns control mediated required addition specific activated responses translation nucleus mirna mitochondrial
16 0.0309 preprint covid cases license copyright medrxiv holder author/funder peer-reviewed sars-cov https://doi.org doi china display number granted perpetuity international made data wuhan days figure reported confirmed epidemic biorxiv coronavirus infected countries ncov rate case cc-by-nc-nd time disease infection rights reuse reserved january permission allowed patients outbreak march population day deaths transmission february virus people period measures province pandemic spread severe estimated early hubei health total table infections study death daily onset symptoms distancing cities chinese italy public based social testing country control due asymptomatic city model including higher date individuals age peak scenario mortality fig high travel incubation analysis growth provinces
15 0.03009 disease blood signs dogs clinical treatment horses normal fluid cases common diagnosis include cats therapy pain increased small examination diarrhea body hours occur abdominal mg/kg serum severe administration affected result heart loss animals days acute intestinal present chronic weight foals concentrations time ferrets pressure surgical muscle large gastric cardiac occurs liver surgery oral performed rabbits weeks age concentration commonly left rate gastrointestinal diet animal patient urine obstruction renal hepatic important administered recommended failure including head protein skin results abnormalities volume bone plasma caused increase diagnostic decreased presence high tissue function secondary tube water diseases condition drugs physical food dose bowel
4 0.02948 mice infection cns brain animals mouse infected day disease cells days virus mhv rats viral observed model neurons microglia astrocytes tissue demyelination animal spinal fig myelin lesions eae compared data rat csf cord levels control p.i detected lungs results studies lung weight liver group clinical loss showed figure inflammatory neuronal dpi acute sections inoculation similar increased models strain tissues shown found time encephalitis brains experimental groups injection study significant matter treatment strains balb/c weeks response titers antibody pathology antigen treated demyelinating macrophages induced number present oligodendrocytes spleen dose cell expression previously nervous damage infiltration multiple neurological differences serum white glial
21 0.02877 activity compounds compound drug acid antiviral inhibitors inhibition drugs treatment effects group showed effect active reported reaction inhibitor inhibitory derivatives concentration activities extract found potent concentrations synthesis table inhibit vitro effective plant cell fig action potential shown extracts obtained inhibited values assay mixture chemical groups results study solution addition properties tested studies isolated yield agents added mmol natural plants toxicity products enzyme ring high cytotoxicity water cells ribavirin synthesized evaluated presence therapeutic exhibited product treated combination scheme including development analogues biological medicinal based human due compared significant screening observed efficacy mechanism prepared dose series method derivative reduction reduced potency formation